Search

everythinglearnresearchcommunity

for

Search:↓

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

Middle Eastern patients with epidermolysis bullosa show specific genetic mutations linked to different types of the disease.

Rat dermal papilla cells have unique genes crucial for hair growth.

IT PEP may help recovery after spinal cord injury, but more research is needed.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Genetic discoveries are leading to new treatments for alopecia areata.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

SSEA-4 can distinguish between eccrine and apocrine sweat gland ducts.

Endocrine disruptors may cause early hair loss.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Two patients with the same genetic mutation had both blistering skin and easily pulled out hair.

Double-stranded RNA activates a pathway that causes a skin protein to be expressed in the wrong place.

A rare case of a transplant patient developing a skin condition linked to HPV-49.

A specific gene variant may increase the risk of developing Alopecia Areata.

A man with a rare skin condition and a new gene mutation developed high calcium levels due to his treatment.

A new mutation in the K6b gene caused a girl's late-appearing nail condition.

Mutations in the KLHL24 gene cause skin blistering in epidermolysis bullosa simplex.

The study created hair-bearing skin models that lack a key protein for skin layer attachment, limiting their use for certain skin disease research.

AR/EDA2R gene linked to early-onset female hair loss, but 20p11 gene not involved.

Removing Mediator 1 causes teeth cells to turn into hair cells.

JAK inhibitors show promise in treating difficult skin diseases.

Certain gene changes in osteopontin are linked to higher risk of atopic dermatitis and asthma.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Mutations in the HOXC13 gene cause hair and nail development issues.

Two new mutations in the CDH3 gene cause hair loss and vision problems in a young girl.